Consistent with these findings in rodents, clinical administration of cholinesterase inhibitors to individuals with mood disorders has shown depression-promoting effects, and in some cases attenuation of mania or hypomania (e.g., refs. 14–16). This evidence concerns the gene BCHE and major depressive disorder.